AKT1 and Hyperglycemia: Taken together, these results demonstrate that miR-291b-3p contributed to hyperglycemia and hepatic insulin resistance through suppressing insulin-stimulated AKT/GSK signaling activation and increasing expression of gluconeogenic genes in hepatocytes.